Contrariwise, the presence in HCC of other proteolytic products of proteoglycans or full-length proteoglycans, such as endostatin and PRG4, is potentially beneficial due to their anti-angiogenic and drug-enhancing abilities. The gene discussed is PRG4; the disease is hepatocellular carcinoma.